HomeAuthorsPosts by admin

admin

1865 POSTS6 COMMENTS

Latest Pharma-News

FDA Encourages Importation of Safe Infant Formula and Other Flexibilities to Further Increase Availability

admin - May 17, 2022 0

Latest Pharma-News

FDA Authorizes First COVID-19 Test Available without a Prescription That Also Detects Flu and RSV

admin - May 17, 2022 0

Latest Pharma-News

First time an albuterol/budesonide fixed-dose combination rescue medication has been shown to reduce severe exacerbations

admin - May 16, 2022 0

Latest Pharma-News

FDA Approves Novel, Dual-Targeted Treatment for Type 2 Diabetes

admin - May 16, 2022 0

Latest Pharma-News

Novo Nordisk and Flagship Pioneering collaborates to create a portfolio of transformational medicines

admin - May 13, 2022 0

Latest Pharma-News

WHO launches new Nursing and Midwifery Community of Practice for International Nurses Day

admin - May 13, 2022 0

Latest Pharma-News

Novartis receives EC approval for Jakavi® for acute and chronic graft-versus-host disease

admin - May 13, 2022 0

Latest Pharma-News

Novartis provides update on production of radioligand therapy medicines

admin - May 13, 2022 0

Latest Pharma-News

Pfizer to Acquire Biohaven Pharmaceuticals

admin - May 12, 2022 0

Latest Pharma-News

University of Aberdeen study finds diabetes almost doubles risk of COVID-19 death

admin - May 11, 2022 0

Latest Pharma-News

Sanofi’s nirsevimab data analyses reinforce efficacy against RSV

admin - May 11, 2022 0

Latest Pharma-News

FDA Takes Important Steps to Improve Supply of Infant and Specialty Formula Products

admin - May 11, 2022 0

1...181920...156 Page 19 of 156

TOP AUTHORS

admin

1865 POSTS6 COMMENTS

OIdMIHuOdiu

0 POSTS0 COMMENTS

tintin

0 POSTS0 COMMENTS

Johnson & Johnson investigational therapy was recently granted U.S. FDA Priority Review for the treatment of gMG

January 24, 2025

Bayer and Pula Foundation partner up to insure 10 million smallholder farmers in Sub-Saharan Africa and South Asia

January 24, 2025

First participants randomized in AskBio Phase II gene therapy trial for Parkinson’s disease

January 18, 2025

Johnson & Johnson initiated submission of NDA application with U.S. FDA for TAR-200 for BCG-unresponsive high-risk non-muscle-invasive bladder cancer

January 18, 2025

admin

TOP AUTHORS

Most Read

Johnson & Johnson investigational therapy was recently granted U.S. FDA Priority Review for the treatment of gMG

Bayer and Pula Foundation partner up to insure 10 million smallholder farmers in Sub-Saharan Africa and South Asia

First participants randomized in AskBio Phase II gene therapy trial for Parkinson’s disease

Johnson & Johnson initiated submission of NDA application with U.S. FDA for TAR-200 for BCG-unresponsive high-risk non-muscle-invasive bladder cancer

EDITOR PICKS

Job Interview Questions for Clinical Data Management 2024

CRASH COURSE ON CLINICAL DATA MANAGEMENT

Interview Questions on Institutional Review Board(IRB)

POPULAR POSTS

How to Find Paid Clinical Trials Near You

What Is CDISC and What Are CDISC Data Standards?

What is Dechallenge, Rechallenge and Prechallenge in Clinical trials?

POPULAR CATEGORY

ABOUT US

FOLLOW US